DXCM
DexCom, Inc.Healthcare$62.22
◆ Neutral
Mkt Cap: $24.27B|Float: 382.9M|SI: 4.3%|DTC: 3.9
Data as of market close Apr 2, 2026
IV Rank
95
IV Pctl
78%
HV 20d
31.2%
52W Range
$54-$90
ATR(14)
$2.08
Exp. Move
±2.0%
P/C Ratio
0.93
Earnings
Apr 30
GEX Negative
DEX Long
Net Put Premium
IV High
Max Pain Above
Exp. Move Narrow
DXCM Key Options Data
- IV Rank
- 94.7%
- Total GEX
- $-0.00B
- Total DEX
- $2.8M
- Max Pain
- $66.00
- Expected Move
- ±2.0%
- Put/Call OI
- 0.93
- Net Premium
- $-0.8M
- Spot Price
- $62.22
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$1.23 | ±2.0% | $61.00 | $63.45 |
| 2026-04-17 | 15 | ±$2.00 | ±3.2% | $60.22 | $64.22 |
| 2026-04-24 | 22 | ±$4.72 | ±7.6% | $57.50 | $66.95 |
| 2026-05-01 | 29 | ±$3.55 | ±5.7% | $58.67 | $65.77 |
| 2026-05-08 | 36 | ±$1.52 | ±2.5% | $60.70 | $63.75 |
| 2026-05-15 | 43 | ±$3.35 | ±5.4% | $58.87 | $65.57 |
Explore DXCM options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.